Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02101736
Title Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

plexiform neurofibroma

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.